Latest News

Innovative Developments in Specialty Therapeutic Areas
Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, discusses specialty areas experiencing innovative developments in therapies.
Two phase 3 studies evaluating the triple combination regimen met the primary endpoint of improvement in lung function in patients with at least 1 F508del mutation.
Top news of the day from across the health care landscape.
Health care providers managing patients with MS should remain cognizant of the link between unhealthy lifestyle behaviors and depression risks.
Thom Cohn, Chief Strategy Officer, Asembia, discusses special considerations for the launch of a personalized drug.
Bodily fluids may serve as vectors for transmission for transmitting hepatitis C virus RNA in patients with a high viral load.
Evolocumab (Repatha) consistently reduced low-density lipoprotein cholesterol in high-risk patients over time.
Top news of the day from across the health care landscape.

Features

Health-System Specialty Pharmacies Becoming an Industry Cornerstone
A new trend is emerging as health system–based specialty pharmacies become a staple in the industry.
Payers and biopharmaceutical companies are increasingly interested in outcomes-based agreements in which payments for a treatment are based on how well it helps patients meet specific health outcomes.
Although there is a persistent need for lower prescription drug costs, this simple concept is complicated by multiple factors.
It's been nearly a year since the new 340B payment rule implemented by the Centers for Medicare and Medicaid Services went into effect.

Featured Company Profile

 
MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy

Videos

Thom Cohn, Chief Strategy Officer, Asembia, discusses special considerations for the launch of a personalized drug.

Robert F. Sidonio Jr, MD, assistant professor of pediatrics at Emory University, Children's Healthcare of Atlanta, gives an overview of the challenges associated with hemophilia management.

Current Issue

November/December
Volume: 9
Number: 7

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$